IL37 and colorectal carcinoma: For example, in a mouse CRC model, interleukin-23 (IL-23) produced by tumor-associated bone marrow cells may be activated by microbial products that penetrate the tumor but not adjacent tissues, thereby triggering tumor-induced inflammation, and eventually driving tumor growth [69].